| (S)-6-[(3,5-Dimethyl-1H-pyrazol-4-yl)methyl]-5-[(4-hydroxyisoxazolidin-2-yl)carbonyl]-1-isobutyl-3-methylthieno[2,3-d]pyrimidine-2,4(1H,3H)-dione |
(S)-6-[(3,5-二甲基-1H-吡唑-4-基)甲基]-5-[(4-羟基异唑烷-2-基)羰基]-1-异丁基-3-甲基噻吩并[2,3-D]嘧啶-2,4(1H,3H)-二酮 |
496791-37-8 |
| UNC3230 |
UNC3230 |
1031602-63-7 |
| GSK2837808A |
1445879-21-9 |
1445879-21-9 |
| Vps34-IN-1 |
VPS34-IN1 |
1383716-33-3 |
| NMS-P937 (NMS1286937) |
4,5-二氢-1-(2-羟基乙基)-8-[[5-(4-甲基-1-哌嗪基)-2-(三氟甲氧基)苯基]氨基]-1H-吡唑并[4,3-H]喹唑啉-3-甲酰胺 |
1034616-18-6 |
| E-4031 |
N-[4-[[1-[2-(6-甲基-2-吡啶基)乙基]-4-哌啶基]羰基]苯基]甲烷磺酰胺二盐酸盐 |
113559-13-0 |
| (4-(3-Benzyloxyphenyl)-2-ethylsulfinyl-6-(trifluoroMethyl)pyriMidine |
BETP |
1371569-69-5 |
| Skp2 Inhibitor C1 |
CS-1230 |
432001-69-9 |
| ALRESTATIN |
阿瑞司他丁 |
51411-04-2 |
| TCS JNK 6o |
JNK INHIBITOR VIII (TCS JNK 6O) |
894804-07-0 |
| Tak-715 |
N-(4-(2-乙基-4-(3-甲基苯基)噻唑-5-基)吡啶-2-基)苯甲酰胺 |
303162-79-0 |
| RO-31-8220 |
RO-31-8220 |
138489-18-6 |
| 3-[N-(2-Hydroxyacetyl)-4-piperidyl]-4-(4-pyrimidinyl)-5-(4-chlorophenyl)pyrazole |
3-[N-(2-羟基乙酰基)-4-哌啶基]-4-(4-嘧啶基)-5-(4-氯苯基)吡唑 |
271576-80-8 |
| N-(2,3-Dihydro-7,8-dimethoxyimidazo[1,2-c]quinazolin-5-yl)-3-pyridinecarboxamide |
N-(2,3-二氢-7,8-二甲氧基咪唑并[1,2-C]喹唑啉-5-基)-3-吡啶甲酰胺 |
677338-12-4 |
| MPEP |
MPEP |
96206-92-7 |
| MIBEFRADIL |
米贝拉地尔 |
116666-63-8 |
| 1-(4-Methoxybenzyl)-5-trifluoromethoxyisatin |
1160247-92-6 |
1160247-92-6 |
| IBOTENIC ACID |
鹅膏氨酸 |
2552-55-8 |
| 4-IBP |
4IBP |
155798-08-6 |
| Ethanone, 2-chloro-1-(3-indolyl)- |
2-氯-1-(1H-吲哚-3-基)-乙酮 |
28755-03-5 |
